Monthly Archives: February 2019

A Look IntoAgera Energy, A NY-Based Energy Supplier

Offering energy supply, efficiency solutions, electricity, and natural gas, Agera Energy is far more than a one-trick pony. Founded in 2014, Agera Energy is touted as an efficient energy provider. Rapidly approaching their fifth anniversary, Agera Energy’s armed millions of individuals with satisfactory energy solutions.

About Agera Energy maintains that they eclipse the competition by focusing on more than just rates. In fact, Agera Energy puts a premium on best customer service. By taking this responsibility seriously, Agera Energy aims to spark a difference.

Since its inception, Agera Energy’s comprised a savvy team of salespeople, marketers, and innovators. Together, this dynamic expert group intends to deliver an unprecedented level of premier business. As Agera Energy continues to evolve, they’ll no doubt amass an ever stronger and more loyal following.

 

“Marc Beer, the CEO of Renovia Leds in Raising of $42 Million For Supporting Women Health “

Marc Beer is the CEO, chairman, and co-founder of Renovia Inc. which was established in August 2016. The Company is involved in developing numerous diagnostic and relaxing products to treat pelvic base disorders like urinary incontinence which approximately affects 250 million women globally. Marc was a graduate of Miami University in Ohio. He happens to possess more than 25 years’ experience as a manager in the pharmaceutical, biotechnology, diagnostic and device industries. A good example is OvaScience Company where he worked as a strategic consultant. Despite being such a busy man, he always makes time for his wife and three children. Speaking of Renovia, They have a new product called Leva which was sanctioned in April the previous year. Marc says that he developed the idea of taking the initiative to look for a solution for pelvic floor disorder from a gynecologist called Dr. Ray Iglesias. Marc is also the founding chairman of the directors’ board, the compensation committee, chairman to the Good Start Genetics Compensation committee (GSGCC) plus a member of Minerva Neurosciences INC Audit committee –MNIAC and also a Business Advisory Council –BAC of Miami University.

 

The Longwood Fund, an investment firm dedicated to health care joined hands with Renovia to advance and test four more therapeutic and diagnostic products including a new cohort of the Leva device. Marc beer Renovia’s CEO commented that “combining our innovative and proprietary sensor technologies and form factors with a digital health platform will give our customers valuable data to inform new treatment options, drive greater knowledge and understanding of pelvic floor disorders and ultimately lower long-term healthcare costs. Recently, it raised $42 million to improve the health of Boston Women. The money will go to product development pipeline and future business launches. Funding in Renovia mostly occurred in its Series A whereby the technology was got from another company. The series B is where Longwood re-instated into Renovia which was led by Ascension Ventures of Missouri and perceptive advisors of New York. It is important to note that the pelvic training product is designed to help women in performing strengthening exercises which is essential. This project will surely save a lot of lives. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing

 

“Dr Saad Saad: A Physician Dedicated To Philanthropy “

The contributions that Dr. Saad Saad has made to medicine are many and even after his retirement, the efforts that he has made are still being remembered. While he was raised in the country of Kuwait, the pediatric surgeon was born in Palestine. Dr. Saad Saad has 7 brothers and sisters who have each achieved a lot in their careers as teachers, surgeons, and engineers. The graduate of Cairo University graduated as the 2nd in his class with honors almost 50 years ago. After moving to England to complete his internship in medicine, Dr. Saad Saad decided to immigrate to the United States to begin his career in medicine where he completed his pediatric surgery and surgery residencies and became USA Board Certified.

 

The Palestinian native was not only dedicated to serving the children in the United States, but he also did several medical missions to help children in Palestine who were suffering from diseases and the injuries of violence. One example was a young teenage boy who was flown to the United States after receiving a gunshot wound to his abdomen. He had difficulty eating because of his injuries and had suffered extensive burns along with the wounds themselves. When Dr. Saad Saad operated on him, he was near the brink of death. The 7-hour surgery that he underwent saved his life and was able to repair the numerous internal injuries that he had suffered.

 

In 2010, yet another child was brought to Dr. Saad Saad to receive life-saving surgery. The one and a half-year-old little girl had been born with a severe birth defect which caused her intestines to be located outside of her body. While the doctors in Palestine had done their best to try to solve the problem, they were unable to because of lack of technology and experience. Dr. Saad Saad was able to create a cover for the birth defect which gave her a second chance at life after a surgery that lasted approximately 5 hours. Learn more: https://www.linkedin.com/in/dr-saad-saad

 

While the surgeries that Dr. Saad Saad performed were admirable, to say the least, the missions that he made in Palestine were able to make a long-lasting impact in the country. Not only did he perform multiple surgeries himself, but he also trained the surgeons in the country on how to perform these surgeries themselves and taught them the methods that he had found such success with. The first mission that Dr. Saad Saad took part in was in 2008 during the month of May. Since then, he had continued to make trips to the war-torn country that is still in desperate need of help from qualified medical professionals. He is dedicated to helping the underprivileged children in the world no matter their background.

 

 

Establish a purpose-driven career with Neurocore

Neurocore is well established and a popularly known brain health center. The organization was incepted in 2004, and since then it has experienced robust growth and expansion. Currently, it has nine brain performance centers spread across Michigan and Florida. Neurocore specializes in providing innovative data-driven brain training and performance to help people concerning the management of stress, concentration, and sleep. The company utilizes science-based and drug-free programs to strengthen your brain. Learn more about Neurocore at Crunchbase.

Neurocore utilizes modern neurofeedback technology to carry out diagnostic measures in their primary areas of expertise such as anxiety, ASD, sleep, migraines, stress, memory, depression, and ADHD. The process begins with a comprehensive initial test using clinically validated diagnosis procedures to derive a clear picture of the brain’s activity. The derived picture is then used to develop a personalized program to come up with a solution.
Follow: https://twitter.com/neurocore

In addition to what they do at their brain centers, Neurocore also posts links to blogs on Twitter to educate the masses on matters regarding brain health and neuroscience. To add on the fantastic services they offer, the organization is among the top workplaces one can ever work at. The work schedules provide a superb work/life balance with highly competitive compensations and guaranteed job security under a friendly management culture. Visit Patch.com to know more about Neurocore.

“Renova Incorporation Continues to Thrive Under the Leadership of Marc Beer “

Marc Beer is the co-founder and CEO of Renovia Incorporation. The MedTech company is based in Boston. Renovia Inc. specializes in developing diagnostic and therapeutic products for treating and managing pelvic floor disorders such as urinary incontinence. Their first product, Leva, was approved by the FDA in April 2018. Research shows that more than 250 million in the world are affected by pelvic floor disorders.

 

Recently, the company obtained $32 million in the Series B round plus $10 million in venture debt, totaling to $42 million. The company is set to continue creating more products for managing pelvic floor disorders. One of the companies that joined the Series B round includes the Longwood Fund, a firm that invests in healthcare companies. The Longwood Fund was also part of Series A funding. Other funders for the Series B include Ascension Ventures, Missouri and Perceptive Advisors, New York.

 

Renovia Inc. intends to use the funds to develop and test four more products for diagnosing and treating pelvic floor disorders. One of the four devices includes the second version of the Leva device. Marc Beer was pleased by the support the company received from its investors. In a statement, he thanked the healthcare investors who share the company’s vision of improving diagnostic and therapeutic methods for pelvic floor disorders.

 

Renovia Inc. aims to give better treatment options, impart knowledge of pelvic floor disorders, and ultimately provide affordable diagnostic and treatment options. Marc believes that the company can achieve its goals by combining the innovative and sensor technology with a digital platform that informs the clients of new treatment options.

Marc Beer has over two decades of experience in the development and commercialization of pharmaceuticals, biotechnology, diagnostics, and devices. He co-founded Renovia Inc. with Yolanda Lorie and Ramon Iglesias, MD in August 2016. The team successfully closed Series A funding with top healthcare investors.

 

Besides Renovia Inc., Marc has founded and co-founded other companies such as ViaCell, a biotech company that majored in collecting, preserving, and developing umbilical cord blood stem cells. Marc led the company from its inception to a robust organization. Under his leadership, ViaCell grew to an employee base of 300. The company went public and was later acquired by PerkinElmer.

 

While serving as the CEO of ViaCell, Mark Beer served at Erytech Pharma in the Board of Directors. Prior to founding ViaCell, Marc served at Genzyme, and he held various positions including the Vice President of Global Marketing where his roles included launching several products that address rare diseases.

 

Marc Beer also held various sales and marketing positions in the pharmaceutical and diagnostic sector of Abbott Laboratories. He also served on the BIO (Biotechnology Industry Association).

The incredible passion and prowess for Marc Beer in building companies are amazing. His go-getter attitude has enabled him to achieve so much in life. Learn more: https://www.crunchbase.com/person/marc-beer